Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study
出版年份 2013 全文链接
标题
Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study
作者
关键词
Quadrivalent meningococcal vaccine, Conjugate vaccine, Bactericidal activity, Persistence, Safety, The Philippines, Saudi Arabia
出版物
BMC INFECTIOUS DISEASES
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-03-05
DOI
10.1186/1471-2334-13-116
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Protective immunity following vaccination: How is it defined?
- (2011) Ian J. Amanna et al. Human vaccines & immunotherapeutics
- Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults
- (2011) Nancy Bermal et al. Human vaccines & immunotherapeutics
- Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2- to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile
- (2011) Ziad A. Memish et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age
- (2011) Roger Baxter et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12–23-month-old children
- (2011) Markus Knuf et al. VACCINE
- Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles–mumps–rubella–varicella vaccine during the second year of life: An open, randomized controlled trial
- (2011) Timo Vesikari et al. VACCINE
- Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States
- (2011) Ziad A. Memish et al. Travel Medicine and Infectious Disease
- Optimizing Protection Against Meningococcal Disease
- (2010) Keith S. Reisinger et al. CLINICAL PEDIATRICS
- Health conditions for travelers to Saudi Arabia for (Hajj) for the year 1431H/2010
- (2010) Ziad A. Memish Journal of Infection and Public Health
- Invasive meningococcal disease and travel
- (2010) Ziad A. Memish et al. Journal of Infection and Public Health
- Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
- (2009) K. S. Reisinger et al. Clinical and Vaccine Immunology
- Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
- (2009) Lisa A. Jackson et al. CLINICAL INFECTIOUS DISEASES
- Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs
- (2009) Caroline L Trotter et al. Expert Review of Vaccines
- Global epidemiology of meningococcal disease
- (2009) Lee H. Harrison et al. VACCINE
- A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
- (2009) M. Knuf et al. VACCINE
- Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
- (2009) S. Black et al. VACCINE
- Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity
- (2008) Martin C. J. Maiden et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search